Purple Biotech Ltd

TASE:PPBT 주식 보고서

시가총액: ₪22.7m

Purple Biotech 과거 수익 실적

과거 기준 확인 0/6

Purple Biotech's earnings have been declining at an average annual rate of -7.9%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been declining at an average rate of 61.3% per year.

주요 정보

-7.9%

수익 성장률

36.0%

EPS 성장률

Pharmaceuticals 산업 성장35.1%
매출 성장률-61.3%
자기자본 수익률-54.8%
순이익n/a
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate

Mar 07
We're A Little Worried About Purple Biotech's (TLV:PPBT) Cash Burn Rate

Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?

Oct 30
Can Purple Biotech (TLV:PPBT) Afford To Invest In Growth?

Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?

Jul 17
Will Purple Biotech (TLV:PPBT) Spend Its Cash Wisely?

Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation

Mar 13
Here's Why We're Watching Purple Biotech's (TLV:PPBT) Cash Burn Situation

Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Nov 27
Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Jul 21
Is Purple Biotech (TLV:PPBT) In A Good Position To Deliver On Growth Plans?

Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

Mar 25
Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth

Dec 09
Companies Like Purple Biotech (TLV:PPBT) Are In A Position To Invest In Growth

Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

May 28
Purple Biotech (TLV:PPBT) Is In A Good Position To Deliver On Growth Plans

We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth

Feb 11
We Think Purple Biotech (TLV:PPBT) Can Afford To Drive Business Growth

If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%

Dec 21
If You Had Bought Purple Biotech's (TLV:KTOV) Shares Five Years Ago You Would Be Down 90%

수익 및 비용 분석

Purple Biotech 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

TASE:PPBT 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 240-16416
31 Mar 240-19417
31 Dec 230-20517
30 Sep 230-21617
30 Jun 230-21615
31 Mar 230-19614
31 Dec 220-22616
30 Sep 220-20615
30 Jun 220-19613
31 Mar 220-19613
31 Dec 210-18612
30 Sep 210-13711
30 Jun 21-1-11711
31 Mar 211-21711
31 Dec 200-2967
30 Sep 201-3056
30 Jun 201-3144
31 Mar 201-1853
31 Dec 190-542
30 Sep 191-443
30 Jun 191-334
31 Mar 191-445
31 Dec 181-545
30 Sep 181-855
30 Jun 181-1165
31 Mar 181-1265
31 Dec 170-1265
30 Sep 170-1455
30 Jun 170-1545
31 Mar 170-1444
31 Dec 160-1234
30 Sep 160-934
30 Jun 160-624
31 Mar 160-523
31 Dec 150-423
30 Sep 150-412
30 Jun 150-412
31 Mar 150-513
31 Dec 140-513
30 Sep 140-513
30 Jun 140-612
31 Mar 140-411

양질의 수익: PPBT is currently unprofitable.

이익 마진 증가: PPBT is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: PPBT is unprofitable, and losses have increased over the past 5 years at a rate of 7.9% per year.

성장 가속화: Unable to compare PPBT's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: PPBT is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (7.1%).


자기자본 수익률

높은 ROE: PPBT has a negative Return on Equity (-54.84%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기